National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Understanding Cancer Series: Molecular Diagnostics
< Back to Main
In English     En español
    Posted: 01/28/2005    Reviewed: 09/01/2006
Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Slide 35  :  Importance of Diagnostic Test Specificity (cont.) <  >  

The next hurdle is a test's specificity. Specificity answers this question: What percentage of the people who do not have cancer are correctly identified as being free of disease? If a cancer test is not very specific, it will yield many "false positive" results; that is, a person will test positive even though they are cancer free. Such error can lead to unnecessary and costly follow-up procedures and cause anxiety in the person misdiagnosed.

Importance of Diagnostic Test Specificity (cont.)

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov